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Brain plasticity after stroke remains poorly understood. Patients may improve
spontaneously within the first 3 months and then more slowly in the coming year. The
first day, decreased edema and reperfusion of the ischemic penumbra may possibly
account for these phenomena, but the improvement during the next weeks suggests
plasticity phenomena and cortical reorganization of the brain ischemic areas and of
more remote areas. Indeed, the injured ischemic motor cortex has a reduced cortical
excitability at the acute phase and a suspension of the topographic representation of
affected muscles, whereas the contralateral motor cortex has an increased excitability
and an enlarged somatomotor representation; furthermore, contralateral cortex exerts
a transcallosal interhemispheric inhibition on the ischemic cortex. This results from the
imbalance of the physiological reciprocal interhemispheric inhibition of each hemisphere
on the other, contributing to worsening of neurological deficit. Cortical excitability
is measurable through transcranial magnetic stimulation (TMS) and prognosis has
been established according to the presence of motor evoked potentials (MEP) at
the acute phase of stroke, which is predictive of better recovery. Conversely, the
lack of response to early stimulation is associated with a poor functional outcome.
Non-invasive stimulation techniques such as repetitive TMS (rTMS) or transcranial
direct current stimulation (tDCS) have the potential to modulate brain cortical excitability
with long lasting effects. In the setting of cerebrovascular disease, around 1000 stroke
subjects have been included in placebo-controlled trials so far, most often with an
objective of promoting motor recovery of the upper limb. High frequency repetitive
stimulation (>3 Hz) rTMS, aiming to increase excitability of the ischemic cortex, or low
frequency repetitive stimulation (≤1 Hz), aiming to reduce excitability of the contralateral
homonymous cortex, or combined therapies, have shown various effects on the
functional disability score and neurological scales of treated patients and on the
duration of the treatment. We review here the patients’ characteristics and parameters
of stimulation that could predict a good response, as well as safety issues. At last, we
review what we have learnt from experimental studies and discuss potential directions
to conduct future studies.
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INTRODUCTION
Stroke is the second leading cause of death, the second leading cause of dementia (Joray et al.,
2009; Ovbiagele and Nguyen-Huynh, 2011; Roger et al., 2011) and the first cause of morbidity
in industrialized countries. Reperfusion therapies such as thrombolysis using recombinant
tissue plasminogen activator (Hacke et al., 2008), and more recently thrombectomy with a stent
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retriever, can rescue brain tissue of the penumbra (a rim
of mild to moderate ischemic tissue around the core of the
infarct), and improves the final neurological outcome (Fransen
et al., 2014). Yet, it remains accessible to less than 5–10%
of the population since the therapeutic window is restricted
to 6 h (Wahlgren et al., 2016). In addition, the development
of neuroprotective pharmacological treatments to limit the
neuronal loss induced by ischemia proved disappointing when
translating from experimental studies to clinical studies (Klein
et al., 1999). The dogma, according to which, any brain injury is
irreversible in adults and cannot be repaired has long prevailed
both in medical schools and at the bedside. Yet, after a stroke,
patients can improve spontaneously within the first 3 months
(Maulden et al., 2005) and thenmore slowly in the following year.
The first day, decreased oedema and partial reperfusion of the
ischemic penumbra may possibly explain these phenomena, but
the improvement of neurological deficit in the following weeks
suggests plasticity phenomena and brain cortical reorganization
(Chen et al., 2002). Restoring arm and hand skill after a stroke
remains challenging, even though stroke rehabilitation programs
have proven partial efficacy. Due to the worldwide increasing
number of strokes predicted for 2030 (Béjot et al., 2016), and
to the restricted number of centers able to provide reperfusion
therapies in a limited therapeutic window, there is a need to
develop new strategies that aim to enhance spontaneous cerebral
plasticity. The complication comes from that, in stroke, post-
lesional brain plasticity may be beneficial or ‘‘adaptive’’ or,
detrimental or ‘‘maladaptive’’ and thus hamper neurological
recovery.
The aim of this study is not to extensively review all the clinical
studies published so far in the literature (for very complete
reviews refer to Simonetta-Moreau (2014), dedicated to stroke, or
Lefaucheur et al. (2014), about Non-Invasive Brain Stimulation
[NIBS] in general neurology). The purpose of this review is rather
to propose mechanisms from clinical and experimental data, and
how up-coming clinical trials could be designed to better address
these issues.
POST-STROKE BRAIN PLASTICITY
Definitions
Cortical plasticity is the capability of the cerebral cortex tomodify
its functional organization as a result of experience (Nudo, 2006).
Consequently, all the changes that occur in brain organization
after a repeated stimulus, refers to ‘‘plasticity’’. Synaptic plasticity
refers to themodification of the strength of synaptic transmission
based on its firing history. All the plasticity forms coexist at a
single synapse. Synaptic transmission can be either enhanced
or depressed, and at various time scales: short-term synaptic
and long-term synaptic plasticity have thus been described.
Long term potentiation (LTP), is the most well-studied process
involved in learning and memory: brain rewires and modifies its
neural network to the formation of new memories. But plasticity
has also been described after brain injury. The definition is purely
descriptive and does not tell us much about the mechanisms
that are involved: it underpins the capacity of the brain to
change its functional and structural organization (histological
and anatomical) in response to injury, to maximize the use of the
remaining undamaged brain.
The Excitability of the Neural Networks
Located Near and Remote from the Injured
Area Is Modified After Stroke
Since most patients recover at least partially, positive or adaptive
plasticity occurs with less or more success. Plasticity mechanisms
include activity-dependent rewiring and synapse strengthening.
A sustained increase of glutamate release through brain derived
nerve factor (BDNF) enhances synaptic activity (Carmichael,
2012). Animal models show that there would be a time-limited
window of neuroplasticity following a stroke, during which the
greatest gains in recovery occur (Murphy and Corbett, 2009). The
challenge is to understand what are the mechanisms involved
in post-stroke recovery to promote them optimally in each
individual.
A further difficulty is that, at the same time, opposing
effects take place. The peri-infarct area presents at the acute
phase a decreased activity in relation with an upregulation
of GABA mediated tonic inhibition (Clarkson et al., 2010).
This has been interpreted as a neuroprotective mechanism to
limit excitotoxicity and neuronal death. Blocking GABAergic
activity during this 1-month period would enhance behavioral
recovery. This decreased activity at the acute phase can
be measured in the patient through transcranial magnetic
stimulation (TMS). The principle developed more than
20 years ago consists of activating the cortex via a coil, inside
which circulates an electric current of high intensity. The brief
discharge of a few microseconds generates a magnetic field of
2–2.5 Tesla for a period of 0.3–1 ms. The magnetic current
generated by the coil placed over the scalp, crosses the skull to
the cortex. According to the Faraday principle, it induces an
electric field in the cortex, which disappears beyond a depth of
approximately 3 cm. This electric field then depolarizes neurons
of the cortex beneath the coil, directly through their axon
hillock or indirectly through depolarization of interneurons.
Consequently, when TMS is applied over the motor cortex,
a contralateral involuntary muscle contraction is elicited; the
resulting motor evoked potential (MEP) is characterized by
its amplitude, correlated to the number of neurons that have
responded to the stimulation, and its latency, which measures
the conduction time between stimulation and the onset of
the MEP. Prognostic criteria have been established in the
setting of stroke: the persistence of a MEP at the acute phase
of stroke after stimulation of the injured hemisphere is a better
predictor of recovery, while the lack of response, indicating a
hypoexcitability, is associated with a poor functional outcome in
the first study, to my knowledge, which prospectively followed
stroke patients up to 1 year (Delvaux et al., 2003); feasibility
studies had been performed earlier, but in those studies, patients
were only followed 14 days (Rapisarda et al., 1996) and 90 days
(Catano et al., 1995). But distant healthy brain regions matter
too: unilateral brain injuries have a remote impact called
‘‘diaschisis’’. This term introduced by von Monakow in 1914
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(Finger et al., 2004) refers to the effects of a focal cerebral lesion
on areas which are anatomically distant, but functionally related
given the underlying connecting neural network (Carrera and
Tononi, 2014). Originally, the concept was mainly clinical, but
is easy to demonstrate through different functional imaging
methods that show a change of the cerebral blood flow in
target regions: the cerebellar diaschisis (Baron et al., 1981) and
the transcallosal diaschisis on the contralateral cortical areas
(Kataoka et al., 1989). The mechanism is a deafferentation i.e.,
the interruption of activation of the healthy target structure, from
the injured cortex (or injured subcortical area). This activation
can be excitatory or inhibitory, resulting in a modification of the
metabolism and local blood flow, according to the neurovascular
coupling principle established by Roy and Sherrington (1890).
The importance of the cortico-cerebellar diaschisis observed at
the acute phase of stroke has been shown to have a negative
predictive value on the clinical outcome at 2 months (Takasawa
et al., 2002). The inter-hemispheric pathway, passing through
the corpus callosum, is rather inhibitory (Schambra et al., 2003).
In the healthy brain, the interhemispheric inhibition is balanced,
that is to say that none of the two hemispheres is a stronger
‘‘inhibitor’’ than the other. After unilateral infarct, increased
cerebral blood flow of the contralateral homonymous area
was evidenced with functional imaging studies and according
to the neurovascular coupling paradigm reflecting thus its
increased activity. Surprisingly, this was correlated to the most
severe deficits (Ward and Frackowiak, 2006). This is interpreted
as that the contralateral hemisphere continues to exert its
inhibitory tone on the ischemic hypoactive hemisphere, thereby
contributing to the worsening of the neurological deficit: the
ipsilateral ischemic cortex becomes doubly impaired, by the
stroke itself and by the exaggerated unbalanced inhibitory
impulse from the healthy contralateral hemisphere. This
imbalanced interhemispheric inhibition is evidenced as soon
as the 1st week after stroke. TMS paired-pulse protocols, allows
evaluation of GABA-A mediated intracortical inhibitory circuits
(short-interval intracortical inhibition) and GABA-B mediated
intracortical inhibitory circuits (long-interval intracortical
inhibition). A longitudinal study of 10 stroke patients followed-
up during 6 months used TMS to identify prognostic factors. It
suggests that recovery, during the acute period, correlates to the
relative integrity of the ipsilateral cortico-spinal pathway of the
affected hemisphere (measured by MEP and motor threshold),
whereas, after the acute phase, it correlates to the development of
alternative neural networks on both hemispheres (as measured
with short- and long-interval intracortical inhibition; Swayne
et al., 2008).
In this small cohort, the importance of the contralateral
hemisphere seemed to be more prevalent in large infarcts and
less important in small infarcts. However, because of the small
cohort and heterogeneous lesions (in the anterior or posterior
circulation territory, cortical or subcortical), extrapolating data
to all stroke patients, is therefore difficult. Yet, in animal studies,
blocking the activity of the unaffected hemisphere by lidocaine
application on rats with a middle cerebral artery occlusion
performed 4 weeks prior to injection worsens the hemiparetic
deficit, especially if large lesions are induced (Biernaskie et al.,
2005). Thus the interhemispheric imbalance at the acute phase
is detrimental but would participate to recovery thereafter.
The constraint induced therapy, now widely used in physical
medicine and rehabilitation units, is the direct implementation
of these observations. The principle is a ‘‘forced’’ use of the
paretic limb and a forced non-used of the healthy limb.
This has two consequences: the corresponding contralateral
primary motor cortical area to stroke is less strongly activated,
limiting its inhibitory transcallosal and deleterious effect on the
ischemic hemisphere and the ispilateral hemisphere is instead
overactivated. In a meta-analysis of randomized studies of
‘‘constraint induced therapy’’, Bonaiuti et al. (2007) concluded
that there is a steady improvement of the paretic limb, yet
without being able to provide a standardized program because
of all the different protocols that were used and of the small
groups of patients. Interestingly, this clinical improvement was
correlated to the doubling of the excitability parameters of
the injured hemisphere measured with TMS (Liepert et al.,
2000).
NON-INVASIVE BRAIN STIMULATION
Repetitive TMS (rTMS) acts like a neurostimulator. It involves
a continuous train or periodic trains of pulses that change the
cortico-spinal excitability and mechanisms could be analogous
to LTP or its counterpart, long term depression (LTD). The daily
stimulation of the same area for about 20 min is repeated for 1
week or 2. The effect depends on the pacing rate. High frequency
stimulation (i.e., >3 Hz) increases cortical excitability while a low
frequency stimulation (i.e.,≤1 Hz) decreases cortical excitability.
This tool is painless and simple to use in an awake patient. The
precise location of the coil over the primary motor cortex (M1) is
easy to verify, since it induces an involuntary contralateral muscle
contraction that can be registered as aMEP. As soon as the target-
stimulated area is outside M1, a real-time neuronavigation,
coupled to the own patient’s cerebral MRI, is recommended to
improve the position of the coil. It requires large and expensive
equipment and cannot be performed at bedside. However, spatial
and temporal resolution is high (Klomjai et al., 2015).
Theta burst stimulation is a modified form of rTMS. It
consists of pulses applied in bursts of three at 50 Hz with an
interburst interval at 5 Hz. Intermittent theta burst stimulation
involves 2 s of TBS trains repeated every 10 s and increases
excitability, whereas continuous theta burst stimulation involves
uninterrupted TBS trains for 20 or 40 s and decreases cortical
excitability (Chung et al., 2016).
Transcranial direct current stimulation (tDCS) acts rather as
a neuromodulator. It is an easier electrophysiological tool to
handle, much smaller and portable at the patient’s bedside. It
delivers weak polarizing direct currents to the cortex via two large
electrodes placed on the scalp. The active electrode is applied
over the targeted cortex area and a direct current generator
(0.5–2 mA) is delivered to modify the threshold of cortical
neurons and the underlying cortex excitability. It is polarity
dependent: anodal stimulation increases the network excitability
and cathodal stimulation decreases the network excitability
(Nitsche and Paulus, 2001a,b). Moreover, because of its size,
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tDCS is easier to apply concomitant with a behavioral task, or
during physical or occupational therapy (Roche et al., 2015).
NON-INVASIVE BRAIN STIMULATION
(NIBS) IN STROKE
More than 1400 publications so far involve NIBS in humans, 230
of these being devoted to stroke. They concern mostly upper
limb motor function assessment and to a lesser degree speech
disorders. More recently some articles treated the impact of NIBS
on post-stroke aphasia, apraxia, neglect, gait and coordination
impairment, but we will focus on motor deficit and NIBS. NIBS
therapeutic strategies, in stroke, were developed to enhance
‘‘adaptive’’ plasticity and to counteract ‘‘maladaptive’’ plasticity.
rTMS
Because of the higher risk of epilepsy at the acute phase, first
feasibility studies were designed to test the inhibition of the
contralateral non affected primary motor area, 3–12 months
after the stroke onset at rTMS (Mansur et al., 2005; Takeuchi
et al., 2005; Fregni et al., 2006). Patients were submitted to a
protocol of a single (30 min; Mansur et al., 2005; Takeuchi
et al., 2005) or repeated sessions (20–30 min a day during
5 working days (Fregni et al., 2006). One study which used
excitatory rTMS on the ipsilateral affected hemisphere was then
conducted in chronic strokes at 10 Hz (Kim et al., 2006),
evaluated immediately after the procedure. For these first four
studies, the number of included patients was relatively small
(10–20). Khedr et al. (2005) showed that there was a benefit
to deliver a high frequency stimulation (3 Hz) to the ipsilateral
affected hemisphere at the acute phase, 10 days after the
onset of stroke, in a larger cohort (n = 52). They showed,
comparing two high-frequency stimulations, that there was no
additional benefit to deliver a higher excitation (10 Hz vs.
3 Hz) of the primary cortex (Khedr et al., 2010). MEP and
motor threshold were also significantly modified in the treated
groups.
These studies were small (even in the larger studies, 20% of
patients were lost to follow-up), but were relatively homogenous
clinically and radiologically with most of the time subcortical
infarcts. They were randomized in a ‘‘crossover’’ study to receive
the real or ‘‘sham’’ stimulation, with a 1 week washout period,
or were randomized to receive one or the other stimulation.
Crossover studies have been used most of the time in patients
submitted to one rTMS session and one sham session separated
by 1 week. The order of the sessions was randomly assigned and
the measurement consisted most of the time on assessing the
strength of hand grip or pinching force and velocity (Takeuchi
et al., 2005; Nowak et al., 2008). When specifically looked
at, the effect of the rTMS had disappeared within 30 min,
suggesting that it did not interfere with the results of the second
session. These crossover studies had the advantage to require
a smaller number of patients. On the contrary, randomization
of patients receiving one or the other stimulation was chosen
after repeated sessions. The ‘‘Sham’’ procedure was not always
described. Variable placebo conditions have been used, such
as changes of the coil orientation (Takeuchi et al., 2005; Kim
et al., 2006) or of the target area (Nowak et al., 2008). ‘‘Sham
coils’’ have been manufactured delivering a magnetic field of
only 10% of the effective coil. They are supposed to deliver a
persistent cutaneous somatosensory sensation, similar to the one
provided by the real coil over the scalp (Fregni et al., 2006),
but the sensation is not quite the same (Loo et al., 2000). In
other articles, no magnetic current was delivered (Avenanti et al.,
2012). In that last case, the patient did not had any sensation
over the scalp, but the authors justified this placebo procedure
by putting forward that the patients were naïve to rTMS and
thus had no mean of comparison (used in randomized groups).
This might be true if the patients included in the real arm or
in the sham arm did not talk together after the session. This
crucial aspect of controlled trials at rTMS has been extensively
discussed previously (Lefaucheur et al., 2014). Clinical evaluation
was performed using manual skills (finger tapping), neurological
scores (NIH Stroke Scale (NIHSS), Scandinavian stroke scale)
and/or disability scores (Barthel, Fugl-Meyer scales). These last
scales have the advantage of better considering a global function
and the consequence of improvement in daily living, rather than
a relative improvement of finger dexterity. Improvement was
seen immediately at the end of the procedure, with a long-
lasting effect obtained when the stimulation was repeated 5 or
10 days (Khedr et al., 2005; Fregni et al., 2006), up to 1 year
(Khedr et al., 2010). Finally, a study evaluated the benefit in
19 patients, 12 months after the stroke onset of a combination
therapy of high-frequency repetitive stimulation (20 Hz) on
the affected ipsilateral hemisphere and concomitant ‘‘constraint-
induced therapy’’ during 10 working days, This study did not
support the adjuvant use of rTMS to the constraint induced
therapy, which does not preclude a possible improvement when
performed at an earlier stage of the disease (Macolm et al.,
2007).
These studies paved the way for all subsequent trials.
Three meta-analyses, including controlled randomized studies
and excluding studies where evaluation was only assessed by
neurophysiological measurement, were controversial (Klomjai
et al., 2015).
• ACochrane database analysis of the ability of rTMS to improve
motor function after stroke selected 19 randomized controlled
trials and 588 patients between 2002 and 2012, regardless of the
delay after stroke (4 h to 6 years), the ischemic or hemorrhagic
type, the cortical or subcortical location, the initial severity,
the type of evaluation, but they excluded studies where
only electrophysiological parameters were assessed. The study
failed to support the use of rTMS for stroke rehabilitation (Hao
et al., 2013).
• Hsu et al. (2012), selected 18 studies and 392 patients between
1990 and 2011. By contrast with the Cochrane review, they
showed that the effect of NIBS wasmore effective in improving
daily living activities and motor function in subgroups of
patients with subcortical infarcts, and with a protocol using
low frequency rTMS over the unaffected hemisphere. One
may speculate that because overlying cortex is intact, plastic
capacities are preserved.
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• A meta analysis on the effect of rTMS on post-stroke aphasia
selected seven studies involving 160 patients, between January
1965 and October 2013. They concluded that low-frequency
rTMS with a 90% resting motor threshold that targets the
triangular part of the right inferior frontal gyrus has a positive
effect on language recovery but that further studies with larger
populations are required to assess the long-term effects of
rTMS (Ren et al., 2014). Otal et al. (2015) confirmed this
promising approach with cathodal tDCS or low-frequency
rTMS.
These meta-analyses of very heterogeneous studies do not
reflect the results of individual studies. Some points deserve a
specific attention (Lüdemann-Podubecká et al., 2015): there is a
more positive effect of facilitatory rTMS at the acute phase and
inhibitory rTMS at the chronic phase. NIBS is more effective
in case of subcortical infarcts, in mild to moderate motor hand
deficit and in males (but who have stroke at an earlier age
than women thus providing a bias in the interpretation of these
data). When rTMS is applied over a maximum of five sessions,
it provides long-lasting effects, with no further benefit when
applied during 10 sessions.
tDCS
tDCS holds particular promise because the equipment is
inexpensive and easier to manipulate, comparatively to rTMS.
As for rTMS, there is also evidence that repeated sessions of
tDCS induce a longer duration of motor deficit recovery. In
line with the paradigms used with the rTMS protocols, cathodal
stimulation of the unaffected hemisphere, to inhibit abnormally
high levels of interhemispheric inhibition from the contralesional
M1, and anodal stimulation of the affected hemisphere, to reverse
the ipsilesional hypoexcitability, have been proposed. As for
rTMS, repeated sessions of tDCS, have mainly been performed at
the chronic stage of the disease. Boggio et al. (2007) have shown
that hand motor function, blindly evaluated with the Jebsen-
Taylor Hand function test, improved after either cathodal tDCS
of the unaffected hemisphere or anodal tDCS of the lesional
hemisphere, when compared to sham tDCS. Moreover, there
was a long lasting effect of at least 2 weeks when cathodal
tDCS was performed five consecutive days. Lindenberg et al.
(2010) assessed the beneficial additional bihemispheric tDCS
stimulation (cathodal stimulation of the unaffected hemisphere
and anodal stimulation of the affected hemisphere) of 20
chronic (>5 months) stroke patients submitted to simultaneous
physical/occupational therapy. The improvement of the motor
function was greater in the group treated by real stimulation
(+21% in Fugl-Meyer and 19% in Wolf Motor Function test
scores) compared to the sham stimulation, and lasted at least
1 week. Moreover, cerebral functional magnetic resonance
imaging (fMRI) showed a stronger activation of the ipsilesional
primary and premotor cortex during paced movements of the
affected limb in the real stimulation group only. The same gain
of function was obtained by others (Stagg et al., 2012; Goodwill
et al., 2016), but in this last study, patients were separated into
three groups evaluating separately the three conditions (cathodal
vs. anodal vs. sham stimulation) although a lesser effect on hand
motor deficit was observed (5–10%). In the same line, Rocha
et al. (2016) compared these three strategies to constraint induced
movement therapy, in order to reinforce the ‘‘rebalancing’’ of
cortical excitability between the two hemispheres. This trial was
double-blind sham controlled and upper limb motor recovery
was assessed with the Fugl-Meyer assessment, the motor activity
log scale and the handgrip strength at the end of the 4 weeks
session, the tDCS being performed three times a week. The
anodal tDCS only achieved an improvement in the Fugl-Meyer
assessment score. Altogether, the ipsilesional anodal tDCS seems
to have a greater impact than contralesional cathodal tDCS
and sham stimulation on motor function of chronic stroke
patients. Using a paradigm of bilateral tDCS combined with
upper extremity robot-assisted therapy over 2 weeks, Straudi
et al. (2016) showed that the Fugl Meyer assessment score was
significantly better in chronic stroke patients with a subcortical
lesion than in patients in a subacute phase after stroke or with a
cortical stroke.
Two recent meta-analyses could not solve the controversy of
whether tDCS is effective in long term motor recovery.
• Marquez et al. (2015) selected 15 studies with 315 patients.
Cortical stimulation did not statistically improve motor
performance when measured immediately after the
intervention whatever the anodal, cathodal or bihemispheric
stimulation. However in subgroups with chronic and
moderate impairments, improvement was statistically
significant.
• The Cochrane review (Elsner et al., 2013) selected 15 studies
with 455 patients. They could not conclude that there was a
strong evidence of effectiveness of tDCS in stroke.
Combined Approaches
Whether there is a potential effect when combining NIBS, either
using rTMS or tDCS, with intensive physical therapy, constraint-
induced therapy (Macolm et al., 2007), robot-therapy (Hesse
et al., 2007; Triccas et al., 2015), EMG-triggered functional
neuromuscular stimulation (Theilig et al., 2011) is controversial
and could not be evidenced in recent studies. The reason of this
failure is unclear. The first hypothesis is that there might be
a ceiling effect obtained after the first procedure. The second
hypothesis is that instead of a priming effect induced by the
first procedure, on the contrary, an inhibitory effect of the
adjuvant therapy is produced. This should be understood in
the light of what is known about metaplasticity, that is the
plasticity of plasticity, meaning that activity-dependent synaptic
plasticity has beenmodified by prior synaptic activity, whichmay
shift the threshold for LTP and LTD induction (Cassidy et al.,
2014); or homeostatic plasticity for homeostasis of plasticity,
which provides a means for neurons and circuits to maintain
functions stable in the face of synaptic perturbations (Bolognini
et al., 2009). In that respect, NIBS, according to the moment it
is applied (before, during, or after neurorehabilitation), could
interact with the motor task and have opposite and invalidating
effects. The next step should aim at better understanding of the
interaction of motor training and NIBS according to the moment
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it is provided (Kakuda et al., 2012) since it could be an additional
variable that influences the synaptic state.
EXPERIMENTAL DATA
What cellular and molecular mechanisms underlie those
complex mechanisms and are able to take over the effects of
the electrophysiological process is unclear and poorly explored.
In a model of experimental stroke, induced by transient
90 min of middle cerebral artery occlusion, rats were exposed
4 days later to a 1 Hz, 5 Hz, and continuous or intermittent
theta-burst rTMS protocol. At the end of the stimulation
period (Ljubisavljevic et al., 2015), only intermittent theta-burst
rTMS protocol induced differential up-regulation of 52 genes
in rat cortices, these genes being involved in angiogenesis,
inflammation, neuroprotection and cellular repair, all these
mechanisms promoting recovery (Nih et al., 2012; Poittevin
et al., 2013). In the same model, but with a different rTMS
protocol using high-frequency stimulation applied 1 h after
the onset of ischemia, neuroprotective effect was evidenced
via anti-apoptosis of the cells located at the margin of the
infarct (Gao et al., 2010). This result was confirmed after
10 Hz stimulation applied over a 2 week period that showed
an up-regulation of Bcl2- and a down-regulation of bax-
positive cells, together with an improved neurological deficit
(Yoon et al., 2011). Optimal parameters were also investigated
in the same model of experimental stroke. When applying
diverse electrical protocols of stimulation (3–7 days, 0–200 µA,
0–50 Hz), over the ischemic boundary in the epidural space,
best efficacy was obtained at 2 Hz and 100 µA: infarct volume
was reduced, neurological deficit and cerebral blood flow were
improved, angiogenesis was increased and inflammatory cells
were diminished.Moreover, after 1 week of electrical stimulation,
BDNF, glial cell-derived neurotrophic factor (GDNF) and
vascular endothelial growth factor (VEGF) were up-regulated
in the ischemic penumbra of the treated animals (Baba et al.,
2009).
PREDICTIVE FACTORS OF RECOVERY
AND HOW TO DESIGN FUTURE TRIALS?
Both rTMS and tDCS induce long-term effects, whosemagnitude
of improvement ranges between 10 and 20% (Talelli and
Rothwell, 2006), according to the upper limb motor functional
assessment that have been used in the literature, and after at
least five sessions. High-frequency stimulation on the ispilateral
affected hemisphere at the acute phase (6–29 days) is more
effective than low-frequency stimulation on the contralateral non
affected hemisphere (Sasaki et al., 2013).
Controlled randomized series are usually small and
monocentric, and it is therefore very difficult to propose a
predictable pattern of response to NIBS in stroke. Knowing what
enhances or dampens rTMS effects could help to improve our
therapeutic protocols. Many factors have to be considered that
each may influence the stroke outcome. Five fields of action
could be identified so far.
The first point is related to autorepair mechanism involved in
the first weeks/months after stroke that can contribute to biased
conclusions in NIBS studies. Intrinsic post-stroke recovery is
dependent on disinhibition of redundant neural circuits (the
rubral pathway for the descendant lateral corticospinal pathway
for instance), besides the formation of new neural networks
(Rossini et al., 2007). fMRI focusing on chronic strokes has
shown the contribution of other indirect motor pathways
(reticulospinal, rubrospinal tracts) in upper limb motor recovery
(Bradnam et al., 2012; Lindenberg et al., 2012; Jang et al.,
2013). Baseline clinical evaluation alone has poor prognosis
accuracy on the stroke outcome at 6 months (Gorelick, 2012).
The MEP measured after TMS is more promising since 30%
of the patients who have a complete deficit of the upper
limb still have a MEP, although not fully satisfactory due
to its poor negative predictive value (Pizzi et al., 2009; Di
Lazzaro et al., 2010 ; Stinear et al., 2014). On MRI, the mean
fractional anisotropy value between both sides on the posterior
limb of the internal capsules values, a structural marker of
descending motor corticospinal tracts integrity, at day 30 in
the ipsilateral and contralateral corticospinal tract in the pons,
is an independent predictor factor of motor outcome after
2 years (Puig et al., 2013). An algorithm has been proposed
to identify key predictors of post-stroke motor recovery. It
combines clinical ‘‘SAFE score’’, neurophysiological (presence of
a MEP at the first week) and imaging (mean value of fractional
anisotropy) parameters (Stinear et al., 2012). To identify accurate
prognostic factors is essential to stratify patients in clinical
cohorts, and if possible in order to establish the modulation
value of NIBS on stroke. Moreover, the mean age of the patients
of these cohorts was 58.46 years old (Crosson et al., 2015),
which is lower than the mean age of the stroke population
(75% are over 65 years old; World Health Organization
(WHO)). Because these factors may interfere and bias the final
response, there is a need for pre-randomization stratification
based on prognostic factors using if possible the predicting
recovery potential (PREP) algorithm which combines clinical,
electrophysiological and imaging criteria. Moreover, if one looks
at individual variability in stroke recovery, it might be that
we have to cope with interindividual plasticity potential among
patients. The genetic polymorphism of BDNF val66met induces
a diminished secretion of BDNF, which is strongly involved in
synapse plasticity (Cheeran et al., 2008). Also the polymorphism
within the 5-HT1A receptor C/C is more susceptible to respond
to TMS therapy than C/G and G/G polymorphism (Zanardi
et al., 2007), as are subjects affected by missense mutation
of the GABAA receptor, GABRG2 (R43Q; Fedi et al., 2008).
Therefore, to identify potential responders it will be essential
to strengthen future clinical trials: the BDNF polymorphism,
the cerebral vasoreactivity observed with functional imaging
(Lang et al., 2005; Stagg et al., 2009; Stagg and Johansen-Berg,
2013; Sallustio et al., 2010) or even proton magnetic resonance
spectroscopy (1H-MRS) which allows quantification of brain
metabolites such as GABA and glutamate in a region-specific
manner (Tremblay et al., 2014). Hence, rTMS according to the
meta-analyses and systematic reviews of the literature published
so far, is less efficient if the stroke is initially clinically more
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severe, if integrity of the corticospinal tract is lost, if the infarct
is cortical, and of course, depends on the protocol chosen,
according to the time course of the infarct. Because stroke is
an evolutionary disease, with a different time course between
individuals, patients should be stratified in the studies according
to the factors that have been identified so far to produce good or
bad recovery, using the PREP algorithm for instance, or genetic
polymorphisms.
The second point concerns the ideal stimulated brain area.
Although the targeted region of stimulation has always been
the primary cortex area, stimulating rather premotor areas
present many advantages (Plow et al., 2015). Premotor areas and
supplementary motor area (SMA) are spared during the middle
cerebral artery occlusion (the most frequently encountered in
stroke patients), and imaging studies have shown that there is a
remapping towards these areas in the long-term. The influence
of premotor cortex of the unaffected hemisphere on the M1
affected hemisphere is excitatory in case of large lesions and
inhibitory in case of small lesions, as shown using fMRI and
TMS techniques (Bestmann et al., 2010), and could represent an
alternative strategy in case M1 is injured. Moreover, there is an
expansion of the representation of the distal representation of
the paretic forelimb into the SMA at 3 months in the squirrel
monkey, which is proportionate to the size of the M1 lesion
(Eisner-Janowicz et al., 2008). At last, SMA is implicated in
bimanual complex movements and into programming of these
complex movements, which is an important point to address
in motor skill recovery. Future trials in stroke should aim to
concomitantly evaluate different targets areas as having done in
dystonia (Kranz et al., 2009).
The third point concerns the stimulation parameters. The
NIBS protocol might possibly also have a role in the optimal
response: frequency, intensity, orientation of the coil, pattern,
number of pulses by train, total number of pulses, number
of trains and interstimulus interval, duration of stimulation,
frequency and intensity of stimulation, number of sessions.
The fourth point would be related to the clinical research
itself and better designed studies are an essential point with
double blind control randomized studies and upper limb motor
functional scores as an outcome measure. Indeed, the outcome
measures are also very heterogeneous between studies, from
measuring the reaction time at a brief motor task such as finger
tapping, to scoring motor deficit or limb function (the NIHSS
score, the Scandinavian stroke scale, the Fugl-Meyer scale) or
more general daily-life disability scales (Rankin or Barthel).
The delay of evaluation after the end of stimulation is also
extremely different (immediately after the train of impulses or
3 weeks to 1 year post-stimulation). Few of the studies had
also a neuroimaging/cerebral blood flow or electrophysiological
supplementary measure to strengthen their clinical results and
are not often able to correlate the outcome measures to the
electrophysiological procedure.
The fifth and last point questions the synergistic impact of
adjuvant therapy such as the intensive motor training, constraint
induced therapy and robot assisted therapy. When it must be
given to the patient is not that simple to solve and has been
discussed above. The influence of drugs (the sodium channel
blocker carbamazepine; the calcium channel blocker flunarizine,
the NMDA antagonist receptor dextromethorphane) on cortical
excitability changes elicited by tDCS has been demonstrated
(Bolognini et al., 2009) and they should appear clearly in all
studies.
SAFETY ISSUES
The most frequently reported adverse events are not specific
to the stroke population: mild headache (2.4%), anxiety
(0.3%), neurocardiogenic syncope after initial exposure to
rTMS (0.6%), exacerbation of pre-existing insomnia (0.3%) and
local discomfort at the site of the stimulation (Hao et al.,
2013). In children and adolescents, adverse events are roughly
similar to what is observed in adults: after tDCS protocols,
headache (11.5%), scalp discomfort (2.5%), twitching (1.2%),
mood changes (1.2%), fatigue (0.9%), tinnitus (0.6%), tingling
(11.5%), itching (5.8%), redness (4.7%) and scalp discomfort
(3.1%) have been reported (Krishnan et al., 2015).
The only potential serious adverse side effect is seizures
(Rossi et al., 2009). Some contributing factors have been
isolated from the general experience of NIBS (besides stroke
particularity). In epileptic patients, NIBS may be complicated by
an epileptic seizure during stimulation in 0–3.6%, but it does
not interfere with the course of the disease. The probability
is increased if the plasma concentration of the anti-epileptic
is low, if there is a high frequency of interictal epileptiform
discharges (>10/min), in case of frequent complex temporal
seizures (>4/month); if stimulation has been preceded by a
recent epileptic seizure (<48 h) and if the epileptogenic area
is specifically stimulated. In non-epileptic patients, there is a
higher risk to induce an epileptic seizure if there is a familial
history of epilepsy, if the patients receive regular epileptogenic
psychotropes, if there is a chronic abuse of alcohol or cocaine,
an underlying neurological disease, a severe heart disease, sleep
disorders, if young age, female sex, and according to the
characteristics of the stimulation parameters (high-frequency
stimulation, long lasting train of impulses, short intertrain
interval, motor area stimulation; Rossi et al., 2009; Chervyakov
et al., 2015).
Stroke patients represent a population at risk, since 3–30%
of the patients will develop epilepsy with a maximal risk
during the first year of follow-up, depending on the lesion
size and location, and on genetic and environmental factors
(Pitkanen et al., 2015). However, this complication has been
rarely reported in the general literature of NIBS whatever be the
underlying disease: 16 cases in adults in the safety guidelines
of the use of rTMS (Rossi et al., 2009), and two cases in
children/adolescents (0.67%) treated for a severe depression
(Krishnan et al., 2015). However, in stroke, only small cohorts
were investigated with a limited number of stimulations, and
even less at the acute stage. This should prompt investigators to
respect safety recommendations.
An interesting question is the risk taken for the operator;
although there are no specific data, the exposure for the magnetic
field pulses is considered limited when the operator stays at more
than 0.7 m from the surface of the coil (Rossi et al., 2009).
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CONCLUDING REMARKS
Both rTMS and tDCS induce after effects, whose magnitude of
improvement ranges between 10 and 20% (Talelli and Rothwell,
2006), according to the upper limb motor functional assessment
that have been used in the literature. Tolerance is excellent.
The meta-analyses conclusions do not match with those of
individual clinical trials, but heterogeneity of the stroke history,
the individual susceptibility, the outcome measures, and the lack
of fundamental knowledge on the place to give to adjuvant
therapies and the influence of concomitant drugs complicate
interpretation. At last, the question whether there is a therapeutic
window for synaptic plasticity remains unsolved. It is illusory
to think that rehabilitation strategies can be optimally designed
without understanding all the mechanisms that are invested and
their time course after stroke. Combining approaches enhancing
adaptive plasticity and limiting maladaptive plasticity according
to the stage of the disease, pharmacological, electrophysiological
or physical adjuvant therapy could theoretically improve the
patients’ care, and given the disease complexity, most of all,
should ultimately favor a patient-tailored approach.
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